SE437219B - Forfarande for framstellning av ett stabilt insulinpreparat med protraherad verkan - Google Patents

Forfarande for framstellning av ett stabilt insulinpreparat med protraherad verkan

Info

Publication number
SE437219B
SE437219B SE7600284A SE7600284A SE437219B SE 437219 B SE437219 B SE 437219B SE 7600284 A SE7600284 A SE 7600284A SE 7600284 A SE7600284 A SE 7600284A SE 437219 B SE437219 B SE 437219B
Authority
SE
Sweden
Prior art keywords
protrahered
preparing
procedure
effect
insulin preparation
Prior art date
Application number
SE7600284A
Other languages
English (en)
Swedish (sv)
Other versions
SE7600284L (sv
Inventor
B A Hansen
F H Andresen
Original Assignee
Nordisk Insulinlab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nordisk Insulinlab filed Critical Nordisk Insulinlab
Publication of SE7600284L publication Critical patent/SE7600284L/
Publication of SE437219B publication Critical patent/SE437219B/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/62Insulins
    • C07K14/625Extraction from natural sources
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Endocrinology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Diabetes (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
SE7600284A 1975-01-15 1976-01-13 Forfarande for framstellning av ett stabilt insulinpreparat med protraherad verkan SE437219B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK8375AA DK140801B (da) 1975-01-15 1975-01-15 Fremgangsmåde til fremstilling af et stabilt langtidsvirkende insulinpræparat.

Publications (2)

Publication Number Publication Date
SE7600284L SE7600284L (sv) 1976-07-16
SE437219B true SE437219B (sv) 1985-02-18

Family

ID=8089535

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7600284A SE437219B (sv) 1975-01-15 1976-01-13 Forfarande for framstellning av ett stabilt insulinpreparat med protraherad verkan

Country Status (36)

Country Link
JP (1) JPS5946939B2 (fr)
AR (1) AR213088A1 (fr)
AT (1) AT362492B (fr)
BE (1) BE837600A (fr)
BR (1) BR7600206A (fr)
CA (1) CA1094549A (fr)
CH (1) CH631625A5 (fr)
CS (1) CS208147B2 (fr)
DD (1) DD124379A5 (fr)
DE (1) DE2600971C2 (fr)
DK (1) DK140801B (fr)
EG (1) EG11988A (fr)
ES (1) ES444558A1 (fr)
FI (1) FI66751C (fr)
FR (1) FR2297634A1 (fr)
GB (1) GB1524431A (fr)
GR (1) GR58608B (fr)
HU (1) HU175142B (fr)
IE (1) IE42395B1 (fr)
IL (1) IL48845A (fr)
IN (1) IN143279B (fr)
IT (1) IT1054211B (fr)
KE (1) KE2919A (fr)
LU (1) LU74175A1 (fr)
MX (1) MX4052E (fr)
MY (1) MY7900169A (fr)
NL (1) NL166464C (fr)
NO (1) NO146698C (fr)
NZ (1) NZ179733A (fr)
OA (1) OA05209A (fr)
PL (1) PL99927B1 (fr)
PT (1) PT64696B (fr)
RO (1) RO71576A (fr)
SE (1) SE437219B (fr)
YU (1) YU8376A (fr)
ZA (1) ZA7658B (fr)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK374579A (da) * 1979-09-07 1981-03-08 Nordisk Insulinlab Fremgangsmaade til fremstilling af et injucerbart insulinpraeparat
US4459226A (en) * 1982-02-26 1984-07-10 Eli Lilly And Company Process for recovering insulin
US4801575A (en) * 1986-07-30 1989-01-31 The Regents Of The University Of California Chimeric peptides for neuropeptide delivery through the blood-brain barrier
AU609769B2 (en) * 1987-02-10 1991-05-09 Drug Delivery Systems Inc. Electrolytic transdermal delivery of proteins
US4878892A (en) * 1987-02-10 1989-11-07 Drug Delivery Systems Inc. Electrolytic transdermal delivery of polypeptides
US5629020A (en) * 1994-04-22 1997-05-13 Emisphere Technologies, Inc. Modified amino acids for drug delivery
US5447728A (en) 1992-06-15 1995-09-05 Emisphere Technologies, Inc. Desferrioxamine oral delivery system
US6221367B1 (en) 1992-06-15 2001-04-24 Emisphere Technologies, Inc. Active agent transport systems
US5714167A (en) 1992-06-15 1998-02-03 Emisphere Technologies, Inc. Active agent transport systems
US5643957A (en) 1993-04-22 1997-07-01 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
US5750147A (en) 1995-06-07 1998-05-12 Emisphere Technologies, Inc. Method of solubilizing and encapsulating itraconazole
US6051258A (en) 1995-06-07 2000-04-18 Emisphere Technologies, Inc. Proteinoid emulsions and methods for preparation and use thereof
EP2077132A1 (fr) 2008-01-02 2009-07-08 Boehringer Ingelheim Pharma GmbH & Co. KG Dispositif distributeur, dispositif de stockage et procédé pour la distribution d'une formulation
EP2414560B1 (fr) 2009-03-31 2013-10-23 Boehringer Ingelheim International GmbH Procédé de revêtement d'une surface d'un composant
JP5763053B2 (ja) 2009-05-18 2015-08-12 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング アダプタ、吸入器具及びアトマイザ
JP5658268B2 (ja) 2009-11-25 2015-01-21 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング ネブライザ
US10016568B2 (en) 2009-11-25 2018-07-10 Boehringer Ingelheim International Gmbh Nebulizer
WO2011064164A1 (fr) 2009-11-25 2011-06-03 Boehringer Ingelheim International Gmbh Nébuliseur
WO2011160932A1 (fr) 2010-06-24 2011-12-29 Boehringer Ingelheim International Gmbh Nébuliseur
WO2012130757A1 (fr) 2011-04-01 2012-10-04 Boehringer Ingelheim International Gmbh Appareil médical pourvu d'un récipient
US9827384B2 (en) 2011-05-23 2017-11-28 Boehringer Ingelheim International Gmbh Nebulizer
WO2013152894A1 (fr) 2012-04-13 2013-10-17 Boehringer Ingelheim International Gmbh Pulvérisateur comprenant des moyens de détrompage
JP6643231B2 (ja) 2013-08-09 2020-02-12 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング ネブライザ
EP2835146B1 (fr) 2013-08-09 2020-09-30 Boehringer Ingelheim International GmbH Atomiseur
LT3928818T (lt) 2014-05-07 2023-03-27 Boehringer Ingelheim International Gmbh Purkštuvas ir talpa
JP6580070B2 (ja) 2014-05-07 2019-09-25 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 容器、ネブライザ、及び使用
PL3139984T3 (pl) 2014-05-07 2021-11-08 Boehringer Ingelheim International Gmbh Nebulizator

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1285023A (en) * 1968-08-09 1972-08-09 Novo Terapeutisk Labor As Improvements in or relating to injectable insulin preparations
US3758683A (en) * 1971-04-30 1973-09-11 R Jackson Insulin product

Also Published As

Publication number Publication date
DK8375A (fr) 1976-07-16
BR7600206A (pt) 1976-08-31
NL166464B (nl) 1981-03-16
ZA7658B (en) 1976-12-29
NZ179733A (en) 1978-04-28
AT362492B (de) 1981-05-25
EG11988A (en) 1978-06-30
MY7900169A (en) 1979-12-31
DE2600971A1 (de) 1976-07-22
FI66751C (fi) 1984-12-10
BE837600A (fr) 1976-07-15
LU74175A1 (fr) 1977-03-18
DE2600971C2 (de) 1985-12-12
FI760058A (fr) 1976-07-16
IL48845A0 (en) 1976-03-31
PL99927B1 (pl) 1978-08-31
ATA21376A (de) 1980-10-15
CA1094549A (fr) 1981-01-27
CH631625A5 (en) 1982-08-31
RO71576A (fr) 1980-12-30
FR2297634B1 (fr) 1979-03-30
MX4052E (es) 1981-11-24
CS208147B2 (en) 1981-08-31
HU175142B (hu) 1980-05-28
GB1524431A (en) 1978-09-13
DK140801B (da) 1979-11-19
AU1030776A (en) 1977-07-21
JPS51125299A (en) 1976-11-01
JPS5946939B2 (ja) 1984-11-15
NL7600338A (nl) 1976-07-19
NO760118L (fr) 1976-07-16
DD124379A5 (fr) 1977-02-16
PT64696B (fr) 1977-08-10
ES444558A1 (es) 1977-05-16
NO146698C (no) 1982-11-24
NL166464C (nl) 1981-08-17
SE7600284L (sv) 1976-07-16
YU8376A (en) 1982-06-30
GR58608B (en) 1977-11-10
DK140801C (fr) 1980-04-21
IT1054211B (it) 1981-11-10
IL48845A (en) 1981-06-29
PT64696A (fr) 1976-02-01
IE42395L (en) 1976-07-15
AR213088A1 (es) 1978-12-15
IN143279B (fr) 1977-10-29
FR2297634A1 (fr) 1976-08-13
NO146698B (no) 1982-08-16
FI66751B (fi) 1984-08-31
OA05209A (fr) 1981-02-28
KE2919A (en) 1979-03-30
IE42395B1 (en) 1980-07-30

Similar Documents

Publication Publication Date Title
SE437219B (sv) Forfarande for framstellning av ett stabilt insulinpreparat med protraherad verkan
SE434395B (sv) Analogiforfarande for framstellning av karbostyrilderivat med terapeutisk verkan
SE433804B (sv) Forfarande for framstellning av en farmaceutisk lekemedelsberedning i kapselform med retardeffekt
SE448790B (sv) Forfarande for framstellning av ett dokument
SE420921B (sv) Analogiforfarande for framstellning av kinazolinderivat med terapeutisk verkan
SE435569B (sv) Forfarande for framstellning av en medicinsk tablett med reglerad frigoring
NO146044C (no) Fremgangsmaate for fremstilling av et farmasoeytisk insulin-preparat for rektal bruk
SE7607565L (sv) Forfarande for framstellning av ett antidepressivum
SE426780B (sv) Forfarande for framstellning av ett cefalexinpreparat
SE433745B (sv) Forfarande for framstellning av tetrahydroisokinolinderivat
SE401182B (sv) Furanhydroxamsyraderivat med fungicid verkan
SE432250B (sv) Forfarande for framstellning av ett kinazolinderivat
SE423390B (sv) Foerfarande foer framstaellning av eburnameninderivat
SE422052B (sv) Forfarande for framstellning av vissa angivna 1-fenoxi-2-hydroxi-3-aminofenyl-propylderivat
SE7606538L (sv) Forfarande for framstellning av ett monsterforsett ovanskikt till skidor samt med dylikt skikt forsedd skida
SE7601125L (sv) Forfarande for framstellning av ett cytotoxiskt medel
NO147672C (no) Analogifremgangsmaate for fremstilling av n-aryl-n-(1-l1-4-piperidinyl)-arylacetamider
SE440907B (sv) Forfarande for framstellning av imidazolderivat med farmaceutisk verkan
SE437026B (sv) Forfarande for framstellning av bensopyranderivat med antiallergisk verkan
SE7801664L (sv) Forfarande for framstellning av en komposition med anestetisk effekt
MX3904E (es) Procedimiento para preparar compuestos heterociclicos
SE7705851L (sv) Forfarande for framstellning av en farmaceutisk komposition
SE7512292L (sv) Forfarande for framstellning av naftalenforeningar med terapeutisk verkan
SE405805B (sv) Forfarande for framstellning av ett sekretinpreparat med protraherad verkan
SE7605751L (sv) Forfarande for framstellning av en bensotiazinforening

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 7600284-9

Effective date: 19891201

Format of ref document f/p: F